HEPA Purifiers for Indoor Air Pollution
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if HEPA air purifiers can enhance indoor air quality and reduce respiratory issues in Alaska Native children living in the Yukon-Kuskokwim Delta. Homes in this area often use woodstoves or have smokers, which can worsen air quality. Families with children under five who live in such homes can participate if they don't plan to move and aren't already using HEPA purifiers. Participants will use the provided purifiers and report their child's respiratory symptoms over 12 weeks. The goal is to assess whether cleaner air leads to fewer coughs and wheezes. As an unphased trial, this study allows families to contribute to important research that could improve children's health in their community.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that HEPA purifiers are safe for improving indoor air quality?
Research has shown that HEPA purifiers are safe for home use. These devices clean the air by removing tiny particles called PM2.5, which can harm the lungs. Studies have found that HEPA filters significantly reduce these particles, potentially lessening symptoms like coughing and wheezing, especially for those with lung issues.
No known negative effects arise from using HEPA purifiers at home. They filter the air without releasing harmful substances. Some research suggests that these purifiers can also reduce airborne viruses, providing an additional benefit for indoor air quality.
Overall, using a HEPA purifier is a safe way to make home air cleaner and healthier, particularly if a woodstove is present or if there is tobacco smoke.12345Why are researchers excited about this trial?
Researchers are excited about HEPA purifiers as a treatment for indoor air pollution because they offer a non-invasive and drug-free approach to improving air quality. Unlike standard options like reducing pollution sources or increasing ventilation, HEPA purifiers actively filter out harmful particles from the air, including dust, pollen, and smoke. This method provides a direct and immediate way to enhance indoor air quality, which is particularly appealing for those with respiratory conditions or allergies. Moreover, the ease of use and accessibility of HEPA purifiers make them an attractive option for a wide range of environments, from homes to offices.
What evidence suggests that HEPA purifiers are effective for improving indoor air quality and reducing respiratory symptoms in children?
Research has shown that HEPA air purifiers effectively reduce indoor air pollution. They lower tiny particles, such as PM2.5, by about 50-60%. These particles can harm the lungs. By reducing them, HEPA purifiers help decrease breathing problems like coughing and wheezing, especially in homes with woodstoves or smokers. In other settings, HEPA filters have reduced fine particles by more than half, resulting in cleaner air. This trial will provide participants with HEPA purifiers to use daily for 12 weeks, aiming to improve air quality and reduce breathing issues in the YK Delta region.678910
Are You a Good Fit for This Trial?
This trial is for Alaska Native families with a child under 5 years old living in homes using woodstoves or where someone smokes. It aims to improve air quality and reduce respiratory issues by testing HEPA purifiers.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants set up and operate HEPA purifiers and air monitoring equipment in their homes, with weekly reporting of child's respiratory symptoms
Follow-up
Participants return air monitoring equipment and are monitored for any changes in respiratory symptoms
What Are the Treatments Tested in This Trial?
Interventions
- HEPA Purifiers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alaska Native Tribal Health Consortium
Lead Sponsor